NCT07468136 2026-04-13
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
Phase 1/2 Not yet recruiting
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
University Hospital, Montpellier